Fresenius SE & Co. (FSNUY) Stock Price, News & Analysis

Company Overview

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Key Stats

• Today's Range: $12.21 to $12.33
• 50-Day Range: $11.09 to $12.85
• 52-Week Range: $7.43 to $12.97
• Volume: 14,047 shs
• Average Volume: 54,970 shs
• Market Capitalization: N/A
• P/E Ratio: 64.69
• Dividend Yield: 1.55%
• Price Target: N/A
• Consensus Rating: Buy

FSNUY Stock Analysis - Frequently Asked Questions

How have FSNUY shares performed this year?

Fresenius SE & Co.'s stock was trading at $8.75 at the beginning of the year. Since then, FSNUY stock has increased by 40.5% and is now trading at $12.29.
View the best growth stocks for 2025 here.

How were Fresenius SE & Co.'s earnings last quarter?

Fresenius SE & Co. (OTCMKTS:FSNUY) announced its quarterly earnings results on Wednesday, May, 7th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.22 by $0.01. The firm had revenue of $5.92 billion for the quarter, compared to analyst estimates of $5.41 billion. Fresenius SE & Co. had a trailing twelve-month return on equity of 9.06% and a net margin of 1.92%.

How do I buy shares of Fresenius SE & Co.?

Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/07/2025
• Ex-Dividend for 6/4 Dividend: 5/27/2025
• Record date for 6/4 Dividend: 5/28/2025
• Dividend Payable: 6/04/2025
• Today: 6/25/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:FSNUY
• CIK: N/A
• Web: www.fresenius.com
• Phone: (496) 172-6080
• Fax: N/A
• Employees: 176,486
• Year Founded: 1912

Profitability

• EPS (Most Recent Fiscal Year): $0.19
• Trailing P/E Ratio: 64.69
• Forward P/E Ratio: 15.56
• P/E Growth: N/A
• Net Income: $509.67 million
• Net Margins: 1.92%
• Pretax Margin: 7.17%
• Return on Equity: 9.06%
• Return on Assets: 4.17%

Debt

• Debt-to-Equity Ratio: 0.50
• Current Ratio: 1.43
• Quick Ratio: 1.11

Sales & Book Value

• Annual Sales: $23.63 billion
• Price / Sales: N/A
• Cash Flow: $1.30 per share
• Price / Cash Flow: 9.44
• Book Value: $9.83 per share
• Price / Book: 1.25

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.76